95 related articles for article (PubMed ID: 29599346)
21. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
Bacalbasa N; Dima S; Brasoveanu V; David L; Balescu I; Purnichescu-Purtan R; Popescu I
World J Surg Oncol; 2015 Aug; 13():235. PubMed ID: 26243426
[TBL] [Abstract][Full Text] [Related]
22. [Low-grade serous ovarian carcinoma: A retrospective study on 34 complete cytoreductive surgeries].
Zaccarini F; Roosen A; Sanson C; Maulard A; Scherier S; Pautier P; Leary A; Chargari C; Morice P; Gouy S
Gynecol Obstet Fertil Senol; 2021 Oct; 49(10):750-755. PubMed ID: 33933671
[TBL] [Abstract][Full Text] [Related]
23. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
25. Survival of patients with advanced ovarian cancer treated with intermittent chemotherapy following cytoreductive surgery and adjuvant chemotherapy.
Amikura T; Aoki Y; Kase H; Watanabe M; Sato T; Fujita K; Kurata H; Tanaka K
Int J Clin Oncol; 2002 Feb; 7(1):45-50. PubMed ID: 11942049
[TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
Tang L; Zheng M; Xiong Y; Ding H; Liu FY
Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
[TBL] [Abstract][Full Text] [Related]
27. [Results of cytoreductive surgery for advanced and recurrent ovarian neoplasms and papillary serous carcinomas of the peritoneum].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2004; 43(5):36-8. PubMed ID: 15518283
[TBL] [Abstract][Full Text] [Related]
28. "The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Cuesta-Guardiola T; Peregrin I; Mendizabal E; Lizarraga S; Ortiz-Quintana L
Surg Oncol; 2016 Mar; 25(1):49-59. PubMed ID: 26979641
[TBL] [Abstract][Full Text] [Related]
29. A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer.
Zikan M; Fischerova D; Pinkavova I; Slama J; Weinberger V; Dusek L; Cibula D
Gynecol Oncol; 2015 May; 137(2):291-8. PubMed ID: 25720294
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer.
Kommoss S; Rochon J; Harter P; Heitz F; Grabowski JP; Ewald-Riegler N; Haberstroh M; Neunhoeffer T; Barinoff J; Gomez R; Traut A; du Bois A
Ann Surg Oncol; 2010 Jan; 17(1):279-86. PubMed ID: 19898901
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for advanced ovarian cancer.
Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Itamochi H; Terakawa N
Eur J Surg Oncol; 1993 Jun; 19(3):273-8. PubMed ID: 8314386
[TBL] [Abstract][Full Text] [Related]
32. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
33. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
34. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
[TBL] [Abstract][Full Text] [Related]
35. Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy.
Gouy S; Belghiti J; Uzan C; Canlorbe G; Gauthier T; Morice P
Int J Gynecol Cancer; 2013 Nov; 23(9):1699-703. PubMed ID: 24100589
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
Gao KF; Liu FY; Chen FJ; Feng YL
Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
[TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis of prognostic factors for stage III ovarian epithelial carcinoma].
Wu M; Shen K; Lang JH; Huang RL; Huang HF; Pan LY
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1406-9. PubMed ID: 16029654
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Sep; 126(3):381-6. PubMed ID: 22609747
[TBL] [Abstract][Full Text] [Related]
39. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Fotopoulou C; Zang R; Gultekin M; Cibula D; Ayhan A; Liu D; Richter R; Braicu I; Mahner S; Harter P; Trillsch F; Kumar S; Peiretti M; Dowdy SC; Maggioni A; Trope C; Sehouli J
Ann Surg Oncol; 2013 Apr; 20(4):1348-54. PubMed ID: 23054114
[TBL] [Abstract][Full Text] [Related]
40. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
